Effectiveness of the FearNot!v.2.0 Software in Reducing Bullying Victimisation Among Primary School Children

NCT ID: NCT00597337

Last Updated: 2008-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1129 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the effectiveness of a virtual learning treatment in reducing bullying among primary school children in the UK and Germany.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, a virtual learning environment application called FearNot!v.2.0 will be evaluated as a way to improve the quality of life in schools by altering children's attitudes and behavior towards bullying.

Participants will be assigned to either the intervention or the control group. The intention was to assign randomly, however, only a minority of primary schools have the computer facilities to run the software with all pupils participating. Thus, assignment is based on the school computer compatibility with the FearNot!v.2.0 software for intervention versus control group controlling for social variables. Participants in the intervention group will interact with the software during 30-minute sessions once a week for a total of 3 weeks while participants in the control group will follow the normal curriculum.

The FearNot! narrative comprises a number of emergent episodes, which play out like an improvisational drama. During each of these emergent episodes, the characters will act out their roles resulting in a dramatic movie-like display on the computer's monitor. In between each of these episodes, the child can interact with the victim character. He/she can learn how the character feels, and offer them coping strategy advice as to how to behave in the following episode.

Outcomes will be assessed through student questionnaires at baseline, one week, and four weeks after treatment. In addition, classroom teachers will be asked to complete the Teacher Incidence of Bullying Scale at baseline and 4 weeks after the treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bullying Victimisation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

bullying victimisation aggressive behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Receiving FearNot

Group Type EXPERIMENTAL

FearNot

Intervention Type BEHAVIORAL

Behavioral: Three sessions of FearNot!v.2.0 software interaction over a three-week period (each session lasting approximately 30 minutes)

2

Control: Treatment as usual (normal curriculum)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FearNot

Behavioral: Three sessions of FearNot!v.2.0 software interaction over a three-week period (each session lasting approximately 30 minutes)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mixed
* Not currently involved in intervention studies specific to countering bullying
* Access to computers that are compatible to run FearNot!v.2.0 (for intervention schools)


* Age between 8-11
* Passive parental consent

Exclusion Criteria

* Enrolled in special education schools
Minimum Eligible Age

8 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Wuerzburg

OTHER

Sponsor Role collaborator

University of Hertfordshire

OTHER

Sponsor Role collaborator

University of Bamberg

OTHER

Sponsor Role collaborator

European Commission

OTHER

Sponsor Role collaborator

University of Warwick

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Warwick

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dieter Wolke, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Warwick

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Warwick

Coventry, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Sapouna M, Wolke D, Vannini N, Watson S, Woods S, Schneider W, Enz S, Hall L, Paiva A, Andre E, Dautenhahn K, Aylett R. Virtual learning intervention to reduce bullying victimization in primary school: a controlled trial. J Child Psychol Psychiatry. 2010 Jan;51(1):104-12. doi: 10.1111/j.1469-7610.2009.02137.x. Epub 2009 Aug 24.

Reference Type DERIVED
PMID: 19703096 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IST-4-027656-STP

Identifier Type: -

Identifier Source: secondary_id

WAR-IST-4-027656-STP

Identifier Type: -

Identifier Source: org_study_id